Ibrahim D. Bori

Array ( [id] => 19156008 [patent_doc_number] => 20240148715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => TREATMENT OF CARDIOPULMONARY DISORDERS [patent_app_type] => utility [patent_app_number] => 18/506944 [patent_app_country] => US [patent_app_date] => 2023-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88384 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18506944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19226645 [patent_doc_number] => 12006278 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-06-11 [patent_title] => 4,4'-naphthalene-1,5-diylbis(diazene-2,1-diyl)diphenol as an antioxidant compound [patent_app_type] => utility [patent_app_number] => 18/385802 [patent_app_country] => US [patent_app_date] => 2023-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3771 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18385802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19180962 [patent_doc_number] => 11987543 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-05-21 [patent_title] => 8-(4-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound [patent_app_type] => utility [patent_app_number] => 18/385535 [patent_app_country] => US [patent_app_date] => 2023-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3718 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18385535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19186163 [patent_doc_number] => 20240165076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA [patent_app_type] => utility [patent_app_number] => 18/497653 [patent_app_country] => US [patent_app_date] => 2023-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16259 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18497653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18938192 [patent_doc_number] => 20240033331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => REDUCING IMMUNOGENICITY TO PEGLOTICASE [patent_app_type] => utility [patent_app_number] => 18/376677 [patent_app_country] => US [patent_app_date] => 2023-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21678 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18376677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19316737 [patent_doc_number] => 20240238277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => METHODS OF TREATING DEPRESSION WITH VORTIOXETINE [patent_app_type] => utility [patent_app_number] => 18/474538 [patent_app_country] => US [patent_app_date] => 2023-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28321 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18474538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19778492 [patent_doc_number] => 12227516 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-02-18 [patent_title] => Selective COX-2 inhibition of 2-(substituted benzyl)-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-ones and 4-fluoro-n-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)benzamide as anti-inflammatory agents [patent_app_type] => utility [patent_app_number] => 18/371095 [patent_app_country] => US [patent_app_date] => 2023-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6351 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18371095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18860152 [patent_doc_number] => 20230414586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => METHODS OF TREATING HYPERSENSITIVE COUGH OR ITCHING USING ION CHANNEL INHIBITORY COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/460648 [patent_app_country] => US [patent_app_date] => 2023-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18938095 [patent_doc_number] => 20240033234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/447040 [patent_app_country] => US [patent_app_date] => 2023-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23092 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18447040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18815900 [patent_doc_number] => 20230390239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => FORMULATIONS AND METHODS RELATED TO EYE IRRITATION AND RELATED [patent_app_type] => utility [patent_app_number] => 18/348193 [patent_app_country] => US [patent_app_date] => 2023-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24415 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18348193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19032399 [patent_doc_number] => 20240082214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => RELATED FORMULATIONS AND METHODS RELATED TO EYE IRRITATION [patent_app_type] => utility [patent_app_number] => 18/348237 [patent_app_country] => US [patent_app_date] => 2023-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24404 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18348237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18842493 [patent_doc_number] => 20230404897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => SKIN CARE EMULSION COMPOSITION WITH CLEAN POLYMERS AND EMULSIFIERS [patent_app_type] => utility [patent_app_number] => 18/335261 [patent_app_country] => US [patent_app_date] => 2023-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10643 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18335261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18786339 [patent_doc_number] => 20230374411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => DETERGENT FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/320284 [patent_app_country] => US [patent_app_date] => 2023-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8330 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18320284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18860333 [patent_doc_number] => 20230414767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => Methods And Compositions For The Treatment Of Cancer [patent_app_type] => utility [patent_app_number] => 18/192210 [patent_app_country] => US [patent_app_date] => 2023-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22301 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18466925 [patent_doc_number] => 20230201205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => TREATING EXTRAPYRAMIDAL SYNDROME USING TRAPIDIL [patent_app_type] => utility [patent_app_number] => 18/176962 [patent_app_country] => US [patent_app_date] => 2023-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19947113 [patent_doc_number] => 12318451 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-03 [patent_title] => Method for inducing tumor regression [patent_app_type] => utility [patent_app_number] => 18/107162 [patent_app_country] => US [patent_app_date] => 2023-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6998 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18107162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19777397 [patent_doc_number] => 12226417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists [patent_app_type] => utility [patent_app_number] => 18/101986 [patent_app_country] => US [patent_app_date] => 2023-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 15578 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18101986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18360018 [patent_doc_number] => 20230141609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms [patent_app_type] => utility [patent_app_number] => 18/150656 [patent_app_country] => US [patent_app_date] => 2023-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4065 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18391644 [patent_doc_number] => 20230159862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => INTERACTION BETWEEN QUATERNARY COMPOUNDS AND ANIONIC SURFACTANTS - FOAM ENHANCEMENT AND STABILIZATION AND PREFERRED FOAMING ANTIMICROBIAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/053987 [patent_app_country] => US [patent_app_date] => 2022-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21080 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18724240 [patent_doc_number] => 20230338370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => Treatment of Cancer with TOR Kinase Inhibitors [patent_app_type] => utility [patent_app_number] => 17/976471 [patent_app_country] => US [patent_app_date] => 2022-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23096 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17976471 [rel_patent_id] =>[rel_patent_doc_number] =>)